Feasibility and Efficacy of Cognitive-Behavioral Therapy for Patients With ADHD/Behavioral Addiction Comorbidity
Not Applicable
Recruiting
- Conditions
- ADHDBehavioral Addiction
- First Posted Date
- 2025-01-28
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 54
- Registration Number
- NCT06797726
- Locations
- 🇫🇷
CHU La Cavale Blanche, Brest, France
🇫🇷Centre Hospitalier Saint Jacques, Nantes, France
🇫🇷CHRU De Tours, Tours, France
Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress Syndrome
Recruiting
- Conditions
- Viral PneumoniaAcute Respiratory Distress Syndrome (ARDS)
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 150
- Registration Number
- NCT06720818
- Locations
- 🇫🇷
University hospital, Tours, France
Role of BARriers in IgG-Pathogen Interactions At the Mucosal Surface in Human Airways
Not Applicable
Not yet recruiting
- Conditions
- Bronchiectasis Adult
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 30
- Registration Number
- NCT06670937
- Locations
- 🇫🇷
CHRU de Tours, Tours, France
Identification of Diagnosis Biomarkers in the Tears of Alzheimer's Disease Patients: the COG-EYE Pilot Study
Not Applicable
Not yet recruiting
- Conditions
- Alzheimer Disease
- First Posted Date
- 2024-10-28
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 90
- Registration Number
- NCT06661564
- Locations
- 🇫🇷
CHRU de Tours, Tours, France
Method for bAdge-dosi Monitoring of X-ray Exposure Values in Operating Theatre Surgery
Recruiting
- Conditions
- X-Ray
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 240
- Registration Number
- NCT06659939
- Locations
- 🇫🇷
University hospital, Tours, France
Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
Phase 3
Not yet recruiting
- Conditions
- Unresectable Metastatic Colorectal Cancer
- Interventions
- Drug: Avastin, 25 Mg/mL Intravenous Solution
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 244
- Registration Number
- NCT06642844
Effectiveness of the SKILLS Program in the Management of Psychiatric Disorders
Not Applicable
Not yet recruiting
- Conditions
- Psychiatric Disorders
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 60
- Registration Number
- NCT06622993
Problematic Use and Addiction in Primary Care
Not yet recruiting
- Conditions
- Addiction DisordersPrimary Care
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 200
- Registration Number
- NCT06580756
- Locations
- 🇫🇷
CPTS Lanmeur, Lanmeur, France
🇫🇷CPTS Sud Lochois, Ligueil, France
🇫🇷CPTS du Vendomois, Vendôme, France
Development, Standardisation and Standardisation Project for a New Memory Assessment
Recruiting
- Conditions
- Memory Disorders
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 150
- Registration Number
- NCT06564779
- Locations
- 🇫🇷
University hospital, Tours, France
Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis
Phase 3
Not yet recruiting
- Conditions
- Interstitial Lung Disease With Systemic Sclerosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-08-12
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 102
- Registration Number
- NCT06549231